Newbridge Financial Services Group’s Oramed Pharmaceuticals ORMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.25K | Buy |
+1,000
| New | +$2.25K | ﹤0.01% | 1130 |
|
|
2024
Q2 | – | Sell |
-657
| Closed | -$1.92K | – | 1193 |
|
|
2024
Q1 | $1.92K | Hold |
657
| – | – | ﹤0.01% | 997 |
|
|
2023
Q4 | $1.52K | Hold |
657
| – | – | ﹤0.01% | 994 |
|
|
2023
Q3 | $1.72K | Hold |
657
| – | – | ﹤0.01% | 1096 |
|
|
2023
Q2 | $2.35K | Hold |
657
| – | – | ﹤0.01% | 1115 |
|
|
2023
Q1 | $1.43K | Hold |
657
| – | – | ﹤0.01% | 1241 |
|
|
2022
Q4 | $7.9K | Hold |
657
| – | – | ﹤0.01% | 960 |
|
|
2022
Q3 | $4K | Hold |
657
| – | – | ﹤0.01% | 1090 |
|
|
2022
Q2 | $3K | Hold |
657
| – | – | ﹤0.01% | 1120 |
|
|
2022
Q1 | $6K | Hold |
657
| – | – | ﹤0.01% | 1069 |
|
|
2021
Q4 | $9K | Buy |
+657
| New | +$9K | ﹤0.01% | 938 |
|